NPPA releases draft version of proposed retail price calculation for five formulations
The National Pharmaceutical Pricing Authority (NPPA) has released draft version of proposed retail price calculation for five formulations, including a combination of telmisartan IP 40 mg and amlodipine besylate IP, which has a moving annual total (MAT) of Rs. 596.8 crore.
The National Pharmaceutical Pricing Authority (NPP | 24/10/2021 | By Darshana | 370
NPPA fixes retail prices of 11 formulations under DPCO-2013
The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 11 formulations under Drugs Prices Control Order (DPCO) - 2013 based on the decision of 89th authority meeting dated June 28, 2021
The National Pharmaceutical Pricing Authority (NPP | 12/07/2021 | By Darshana | 262
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy